Jfs Wealth Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

Jfs Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$69.53 - $79.33 $139 - $158	2 Added 66.67%	5 $0
Q3 2022 Oct 21, 2022	BUY	$0.01 - $107.56 $0 - $107	1 Added 50.0%	3 $0
Q2 2022 Aug 02, 2022	SELL	$74.52 - $117.06 $223 - $351	-3 Reduced 60.0%	2 $0
Q1 2022 May 02, 2022	BUY	$94.99 - $151.56 $284 - $454	3 Added 150.0%	5 $1,000
Q4 2021 Feb 03, 2022	BUY	$127.69 - $165.85 $255 - $331	2 New	2 $0

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.1B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.